DCAT Value Chain Insights
  • Features
  • Top Industry News
  • DCAT Member Company Community
  • Production to Prescription Podcast
  • Sponsored Content
  • About Us
  • Advertise
  • Add DCAT As A Safe Sender
  • Subscribe/Contact Us
DCAT Value Chain Insights DCAT Value Chain Insights
Home About Us

About Us

Home About Us
DCAT Company Page
    Home About Us

DCAT Value Chain Insights is one of the most widely read and respected online publications for the global Bio/Pharmaceutical industry.

DCAT Value Chain Insights is produced by the Drug, Chemical & Associated Technologies Association, Inc. (DCAT), a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain, providing:

  • In-depth Features: Original in-depth analysis of the business of Bio/Pharmaceutical development and manufacturing, including issues impactful to sourcing, procurement and supply-chain management.
  • Top Industry News: An Executive Briefing of the major news from bio/pharma companies, CDMOs/CMOs/suppliers, and key regulatory developments.
  • DCAT Member Company Community News: News from the DCAT association, including:
    • People on the Move—Promotions and job moves of employees of DCAT Member Companies;
    • New Member Company Alert—New Companies joining the DCAT community;
    • ESG Update: DCAT Member Companies in the Community—Latest news on how DCAT Member Companies are making an impact globally and in their local communities.

Digital distribution and website updated each Friday to keep readers fully informed.

DCAT Value Chain Insights content can be found on this dedicated website and DCAT will notify subscribers and DCAT Member Company contacts via email every Friday with links to the latest content. 

Editorial Questions? Contact Patricia Van Arnum, DCAT’s Editorial Director at pvanarnum@dcat.org, Tel: +1-(856)-388-2964

EDITORIAL
CALENDAR

AUTHOR
GUIDELINES FOR FEATURE ARTICLES

SUBMIT
PRESS RELEASES, COMPANY NEWS, ESG UPDATE


EDITORIAL COMMITTEE

The collective expertise and experience of DCAT’s volunteer Editorial Committee ensures that DCAT Value Chain Insights serves the varying information needs of DCAT Member Companies by delivering topical, salient, and relevant content.

COMMITTEE MEMBERS

Nagarjun Chakilam
Director, Maithri Drugs Private Limited, Committee Chairperson

Louis-David Cantin, Ph.D.
President & CEO, Groupe Parima

Pierre Colin
Head of Finance GBU Pharma, Roquette America Inc.

Claus Feussner, Ph.D.
Senior Vice President, Vetter Development Service

Karen Florjancic
Associate Director, CMC Supply Chain and Program Strategy
Development Sciences, AbbVie

Gavin Murdoch
Vice President, Commercial Strategy, Abzena

Patricia Van Arnum
Editorial Director, DCAT

Jacob White
Editorial Coordinator & Committee Staff Liaison, DCAT 

DCAT Value Chain Insights
GLOBAL HEADQUARTERS

One Washington Blvd., Suite 6

Robbinsville, NJ 08691 USA

+1-609-208-1888

Toll Free: +1-800-640-DCAT (3288)

www.dcat.org

© 2025 DCAT | Privacy Policy

DCAT Value Chain Insights is produced by the Drug, Chemical &
Associated Technologies Association, a not-for-profit business
development association for companies engaged in the Bio/Pharmaceutical business ecosystem. To learn more,
please visit www.dcat.org

  • About Us
  • Advertise
  • Contact Us
  • LinkedIn

Get DCAT Value Chain Insights delivered to your inbox every Friday!

SUBSCRIBE